Align Technology | ALGN - Gross Profit On Sales

Stock Price
187.60
Daily Change
11.98 6.82%
Monthly
12.46%
Yearly
-10.90%
Q1 Forecast
158.01

Align Technology reported $683.59M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
3M USD 2.06B 667M Dec/2025
Align Technology USD 683.59M 44.39M Dec/2025
Becton, Dickinson and Co. USD 696M 1.94B Sep/2025
Bruker USD 379.4M 21.5M Sep/2025
Cardinal Health USD 2.4B 78M Dec/2025
Charles River Laboratories USD 311.39M 6.77M Sep/2025
Cooper Companies USD 650.8M 62.6M Sep/2025
CVS Health USD 13.81B 213M Sep/2025
Danaher USD 3.97B 443M Dec/2025
Dentsply International USD 441M 49M Sep/2025
Dexcom USD 688.8M 99.8M Jun/2025
Henry Schein USD 1.03B 74M Sep/2025
Idexx Laboratories USD 658.11M 25.24M Dec/2025
Insulet USD 510.1M 57.9M Sep/2025
Integra LifeSciences USD 206.99M 2.34M Sep/2025
IQVIA Holdings USD 1.12B 32M Dec/2025
Masimo USD 230.6M 2.7M Sep/2025
McKesson USD 3.68B 143M Dec/2025
Mettler Toledo International USD 675.44M 65.98M Dec/2025
Revvity USD 374.6M 17.95M Sep/2025
Solventum Corp USD 1.14B 40M Sep/2025
Stryker USD 4.49B 633M Dec/2025
Teleflex USD 451.64M 20.56M Sep/2025
Thermo Fisher Scientific USD 4.64B 419M Dec/2025
Veeva Systems USD 629.59M 17.83M Sep/2025
Waters USD 459.99M 21.97M Sep/2025
Zimmer Biomet Holdings USD 1.27B 58.9M Sep/2025
Zoetis USD 1.72B 96M Sep/2025